-
1
-
-
0031693610
-
The cost of treating community-acquired pneumonia
-
Niederman MS, McCombs JS, Unger AN, et al. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20:820-837
-
(1998)
Clin Ther
, vol.20
, pp. 820-837
-
-
Niederman, M.S.1
McCombs, J.S.2
Unger, A.N.3
-
2
-
-
0034959819
-
Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention
-
Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754
-
(2001)
Am J Respir Crit Care Med
, vol.163
, pp. 1730-1754
-
-
Niederman, M.S.1
Mandell, L.A.2
Anzueto, A.3
-
3
-
-
0034458012
-
Practice guidelines for the management of community-acquired pneumonia
-
Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia. Clin Infect Dis 2000; 31:347-382
-
(2000)
Clin Infect Dis
, vol.31
, pp. 347-382
-
-
Bartlett, J.G.1
Dowell, S.F.2
Mandell, L.A.3
-
5
-
-
0032110852
-
Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia
-
Whittle J, Lin CJ, Lave JR, et al. Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia. Med Care 1998; 36:977-987
-
(1998)
Med Care
, vol.36
, pp. 977-987
-
-
Whittle, J.1
Lin, C.J.2
Lave, J.R.3
-
6
-
-
0030031642
-
Prognosis and outcomes of patients with community-acquired pneumonia
-
Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 1995; 274:134-141
-
(1995)
JAMA
, vol.274
, pp. 134-141
-
-
Fine, M.J.1
Smith, M.A.2
Carson, C.A.3
-
7
-
-
0030814756
-
Incidence of community-acquired pneumonia requiring hospitalization
-
Marston BJ, Plouffe JF, File TM, et al. Incidence of community-acquired pneumonia requiring hospitalization. Arch Intern Med 1997; 157:1709-1718
-
(1997)
Arch Intern Med
, vol.157
, pp. 1709-1718
-
-
Marston, B.J.1
Plouffe, J.F.2
File, T.M.3
-
8
-
-
0033805103
-
Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia
-
Fine MJ, Pratt HM, Obrosky DS, et al. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med 2000; 109:378-385
-
(2000)
Am J Med
, vol.109
, pp. 378-385
-
-
Fine, M.J.1
Pratt, H.M.2
Obrosky, D.S.3
-
9
-
-
0032778289
-
Using healthcare claims data for outcomes research and pharmacoeconomic analyses
-
Birnbaum HG, Cremieux PY, Greenberg PE, et al. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 1999; 16:1-8
-
(1999)
Pharmacoeconomics
, vol.16
, pp. 1-8
-
-
Birnbaum, H.G.1
Cremieux, P.Y.2
Greenberg, P.E.3
-
10
-
-
0035842341
-
Economic burden of pneumonia in an employed population
-
Birnbaum HG, Morley M, Greenberg PE, et al. Economic burden of pneumonia in an employed population. Arch Intern Med 2001; 161:2725-2731
-
(2001)
Arch Intern Med
, vol.161
, pp. 2725-2731
-
-
Birnbaum, H.G.1
Morley, M.2
Greenberg, P.E.3
-
11
-
-
0036036433
-
Economic burden of respiratory infections in an employed population
-
Birnbaum HG, Morley M, Greenberg PE, et al. Economic burden of respiratory infections in an employed population. Chest 2002; 122:603-611
-
(2002)
Chest
, vol.122
, pp. 603-611
-
-
Birnbaum, H.G.1
Morley, M.2
Greenberg, P.E.3
-
13
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383
-
(1987)
J Chronic Dis
, vol.40
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
-
17
-
-
0036735465
-
Pharmaceutical industry research and cost savings in community-acquired pneumonia
-
Kessler LA, Waterer GW, Barca R, et al. Pharmaceutical industry research and cost savings in community-acquired pneumonia. Am J Manag Care 2002; 8:798-800
-
(2002)
Am J Manag Care
, vol.8
, pp. 798-800
-
-
Kessler, L.A.1
Waterer, G.W.2
Barca, R.3
-
18
-
-
0037541094
-
Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia
-
Brown RB, Iannini P, Gross P, et al. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia. Chest 2003; 123:1503-1511
-
(2003)
Chest
, vol.123
, pp. 1503-1511
-
-
Brown, R.B.1
Iannini, P.2
Gross, P.3
-
19
-
-
0036430388
-
Cost-effectiveness of IV-to-oral switch therapy
-
Paladino JA, Gudgel LD, Forrest A, et al. Cost-effectiveness of IV-to-oral switch therapy. Chest 2002; 122:1271-1279
-
(2002)
Chest
, vol.122
, pp. 1271-1279
-
-
Paladino, J.A.1
Gudgel, L.D.2
Forrest, A.3
-
20
-
-
0031012761
-
A prediction rule to identify low-risk patients with community-acquired pneumonia
-
Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250
-
(1997)
N Engl J Med
, vol.336
, pp. 243-250
-
-
Fine, M.J.1
Auble, T.E.2
Yealy, D.M.3
|